Crohn's

Research News


Researchers update guidance on colorectal cancer screening in patients with IBDs Researchers update guidance on colorectal cancer screening in patients with IBDs
November 4, 2021 - Dr. Sanjay Murthy was the lead author in a Clinical Practice Update (CPU) for the American Gastroenterological Association on how to prevent, detect and manage colorectal neoplastic lesions in patients with inflammatory bowel diseases (IBDs) based on
Unravelling the mystery of how one gene contributes to Parkinson’s, Crohn’s and leprosy Unravelling the mystery of how one gene contributes to Parkinson’s, Crohn’s and leprosy
September 25, 2019 - Researchers have struggled for years to understand how mutations in one gene, called LRRK2, can increase the risk of three very different diseases: Parkinson’s (a brain disease), Crohn’s (a gut disease) and leprosy (a peripheral nervous system diseas
Are we using biologic therapy properly? Are we using biologic therapy properly?
June 13, 2019 - The introduction of infliximab (Remicade), the first biologic therapy approved for the treatment of inflammatory bowel diseases (IBD), did not result in lower rates of hospitalizations or intestinal surgeries among patients living with IBD in Ontario


Related Resources

Search for clinical trials at The Ottawa Hospital related to this disease or condition.